with your 30b valuation ceiling for early 2022 buyout, you valued post 1 at preclinical and 2.5b. given it has the most potential(as per Dr T.) are we not doing it justice?
although I agree with you that we will probably not get a buyout figure that would potential be equal to the success of 3 pillars, would that mean the ultimate deal would be buyout with royalties? Would this type of deal get the most out of pillar 2/3?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
0.500(27.8%) |
Mkt cap ! $399.7M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.30 | $1.96 | $2.905M | 1.362M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8695 | $2.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.30 | 184 | 1 |
View Market Depth
| Last trade - 16.11pm 16/09/2025 (20 minute delay) ? |
| RAC (ASX) Chart |